| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/01/1994 | WO1994018970A1 Cold/sinus preparation consisting of phenindamine tartarate with or without therapeutic agents |
| 09/01/1994 | WO1994018969A1 An effective treatment modality for infectious diseases, pulmonary conditions and sequelae thereof |
| 09/01/1994 | WO1994018968A1 Methods for treating arteriosclerosis |
| 09/01/1994 | WO1994018967A1 Treatments for diseases characterized by neovascularization |
| 09/01/1994 | WO1994018966A1 Transdermal therapeutic system with active substances which represent sources of nitrogen oxide |
| 09/01/1994 | WO1994018965A1 Therapeutic use of pyridoxine pyrrolidone carboxylate |
| 09/01/1994 | WO1994018964A1 USE OF φ-GUANIDINOCARBOXYLIC ACID ESTERS |
| 09/01/1994 | WO1994018963A1 Method of reversing resistance of hiv-1 strains to zidovudine |
| 09/01/1994 | WO1994018962A1 Pharmaceutical compositions for transdermal fenfluramine delivery |
| 09/01/1994 | WO1994018961A1 Cancer treatment |
| 09/01/1994 | WO1994018960A1 Use of 2-chloro-1-[[4-[(2,6-dichlorophenoxy)methyl]-phenyl]methoxy]-4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |
| 09/01/1994 | WO1994018958A1 5-ht2 receptor antagonist compositions useful in treating venous conditions |
| 09/01/1994 | WO1994018951A1 A process for the preparation of substantially alcohol free pharmaceutical compositions |
| 09/01/1994 | WO1994018943A1 Compositions against skin impurities containing di- or triglycerine esters as active principle |
| 09/01/1994 | WO1994018942A1 Synergistic combinations of sunscreening substances, cosmetic and dermatological compositions containing such combinations |
| 09/01/1994 | WO1994018941A1 Skin care composition |
| 09/01/1994 | WO1994018938A1 Calcium glycerophosphate dental health chewing gum |
| 09/01/1994 | WO1994018936A1 Compositions and methods for promoting hair growth |
| 09/01/1994 | WO1994018835A1 Treatment of androgen-associated baldness using antisense oligomers |
| 09/01/1994 | WO1994014776A3 Bicyclic fibrinogen antagonists |
| 09/01/1994 | WO1994013304A3 Antacid composition and method of production |
| 09/01/1994 | WO1994004017A3 New method of treatment |
| 09/01/1994 | WO1993012756A3 Transfection of lung via aerosolized transgene delivery |
| 09/01/1994 | CA2157049A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 09/01/1994 | CA2157041A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | CA2156919A1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 09/01/1994 | CA2156916A1 Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans |
| 09/01/1994 | CA2156826A1 Combination cisplatin/tamoxifen therapy for human cancers |
| 09/01/1994 | CA2156735A1 Pharmaceutical compositions for the treatment of inflammatory or immunological diseases and a method for the treatment of said diseases |
| 09/01/1994 | CA2156635A1 Composition useful for the treatment of tumors and immunization of organisms against tumors |
| 09/01/1994 | CA2156508A1 Chemical compounds useful in photodynamic therapy and production of laser light |
| 09/01/1994 | CA2156497A1 Agent for prophylaxis or treatment of cataract |
| 09/01/1994 | CA2156420A1 Inhibitors of hiv reverse transcriptase |
| 09/01/1994 | CA2156258A1 Substituted heteroarylalkylthiopyridines for controlling helicobacter bacteria |
| 09/01/1994 | CA2156186A1 Chemical compounds |
| 09/01/1994 | CA2156171A1 Method for preparing quinoline carboxylic acids and derivatives thereof |
| 09/01/1994 | CA2156158A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same |
| 09/01/1994 | CA2155953A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | CA2155830A1 Substituted azolone derivatives for treating diseases causes by helicobacter |
| 09/01/1994 | CA2155829A1 Method of reversing resistance of hiv-1 strains to zidovudine |
| 09/01/1994 | CA2155338A1 Retroviral protease inhibiting compounds |
| 09/01/1994 | CA2155123A1 Fibrinogen receptor antagonists |
| 09/01/1994 | CA2153151A1 Polymeric compounds |
| 09/01/1994 | CA2152925A1 Azacyclic compounds compositions containing them and their use as tachykinin antagonists |
| 09/01/1994 | CA2151260A1 A process for the preparation of substantially alcohol free pharmaceutical compositions |
| 09/01/1994 | CA2134328A1 Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors |
| 09/01/1994 | CA2133207A1 Peripheral vasodilators |
| 09/01/1994 | CA2118409A1 Substituted phosphonates, the processes for their preparation and pharmaceutical compositions containing them |
| 09/01/1994 | CA2118317A1 Fluorinated 4-aminoandrostadienone derivatives and process for their preparation |
| 09/01/1994 | CA2118314A1 Methods for treating arteriosclerosis |
| 09/01/1994 | CA2118313A1 Treatments for diseases characterized by neovascularization |
| 08/31/1994 | EP0612760A2 Method for purification of estramustin phosphate or salt thereof |
| 08/31/1994 | EP0612743A1 Oxazolidinedione derivatives, their production and use in lowering blood sugar and lipid levels |
| 08/31/1994 | EP0612742A1 A physiologically active bisindole-pyrrole derivative |
| 08/31/1994 | EP0612741A1 Cyclic derivatives, medicaments containing them and process for their preparation |
| 08/31/1994 | EP0612734A1 Novel orally active antifungal agents |
| 08/31/1994 | EP0612733A1 Use of Phthaloylhydrazide Derivatives as Anti-Hypoxic and defensive Agents |
| 08/31/1994 | EP0612731A1 Novel guinolone and naphthyridone derivatives |
| 08/31/1994 | EP0612730A1 O-aryl ethers of morphinans |
| 08/31/1994 | EP0612728A2 Anisomycin derivatives and anticancer agents, antifungal agents and antiprotozoan agents containing them |
| 08/31/1994 | EP0612724A1 Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use as pharmaceuticals |
| 08/31/1994 | EP0612723A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them |
| 08/31/1994 | EP0612719A1 Hydroxyalkanecarboxylic acid derivatives |
| 08/31/1994 | EP0612531A1 Therapeutic agent for digestive tract diseases |
| 08/31/1994 | EP0612527A2 Use of rhamnan, rhamnose or rhamnose oligomers for the treatment of gastric ulcer |
| 08/31/1994 | EP0612526A1 Anti-inflammatory and analgesic plaster |
| 08/31/1994 | EP0612525A1 Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| 08/31/1994 | EP0612524A1 Angiotensin II antagonists for the treatment of viral diseases |
| 08/31/1994 | EP0612523A1 Vascular hypertrophy suppressor |
| 08/31/1994 | EP0612522A1 Composition and method for reducing the risk of hypotension |
| 08/31/1994 | EP0612521A1 Fomentation containing ketorolac |
| 08/31/1994 | EP0612519A1 Calcium formulation for treating milk cows suffering from hypocalcemia |
| 08/31/1994 | EP0612513A2 External skin treatment composition |
| 08/31/1994 | EP0612323A1 Cns active tetrahydrobenzothienopyridines |
| 08/31/1994 | EP0612321A1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
| 08/31/1994 | EP0612320A1 4,5-dicyanoimidazole derivatives and pesticidal compositions containing them |
| 08/31/1994 | EP0612318A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 08/31/1994 | EP0612317A1 Substituted heterocycles as angiotensin ii antagonists |
| 08/31/1994 | EP0612315A1 Nitro compounds having vasodilator activity |
| 08/31/1994 | EP0612314A1 2-heterocyclicethylamine derivatives and their use as pharmaceuticals |
| 08/31/1994 | EP0612313A1 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation |
| 08/31/1994 | EP0612249A1 Methods of inhibiting restenosis |
| 08/31/1994 | EP0612248A1 Combination chemotherapy |
| 08/31/1994 | EP0612247A1 Use of sulphonyl compounds |
| 08/31/1994 | EP0612246A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/31/1994 | EP0612245A1 Use of alpha-ketoglutarate |
| 08/31/1994 | EP0612244A1 Endothelin receptor antagonists |
| 08/31/1994 | EP0612243A1 Bactericidal pharmaceutical composition containing chlorhexidine and eugenol |
| 08/31/1994 | EP0612242A1 Methods and compositions utilizing pure s(+) isomer fluoxetine |
| 08/31/1994 | EP0612240A1 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 08/31/1994 | EP0612216A1 Phospholipid antimicrobial compositions |
| 08/31/1994 | EP0612211A1 Alteration of rate and character of hair growth |
| 08/31/1994 | EP0561882B1 Hydroxamic acid derivatives which inhibit lipoxygenase |
| 08/31/1994 | EP0549645B1 New 17- -oestradiol derivatives, a method of preparing them, and drugs containing them |
| 08/31/1994 | EP0505413B1 Beta-lactam derivatives |
| 08/31/1994 | EP0496796B1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 08/31/1994 | EP0474733B1 Antihyperlipidemic and antiatherosclerotic urea compounds |
| 08/31/1994 | EP0449935B1 Compound with gastric acid inhibitory effect and process for its preparation |
| 08/31/1994 | EP0408691B1 Antinephrotoxic perfusion solution |